Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2911-2916

  Poggi, Guido ^a   Riccardi, Alberto ^b   Quaretti, Pietro ^c   Teragni, Cristina ^a   Delmonte, Angelo ^a   Amatu, Alessio ^a   Saini, Gaia ^a   Mazzucco, Mauro ^d   Bernardo, Antonio ^a   Palumbo, Raffaella ^a   Canto, Andrea ^a   Bernieri, Simone ^a   Bernardo, Giovanni ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UO Medicina Generale Este (PD) ASL 17   (Italy)

Author keywords

Adverse effects; Catheter ablation; Hepatocellular carcinoma; Interventional procedures; Liver neoplasm; Radiofrequency ablation; RFA; Secondary lesions

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; ARTICLE; ASCITES; BILE DUCT OBSTRUCTION; BODY TEMPERATURE; BURN; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEMATOMA; HEMATOTHORAX; HEMOBILIA; HEMOPERITONEUM; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT DURATION; TREATMENT OUTCOME; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HEMOTHORAX; HUMANS; INFARCTION; LIVER; LIVER ABSCESS; LIVER NEOPLASMS; MIDDLE AGED;

EID: 34547768902     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Monto A and Wright TL: The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28: 441-449, 2001.
2. Kindler HL and Shulman KL: Metastatic colorectal cancer. Curr Treat Options Oncol 2: 459-471, 2001.
3. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan J, Phillips DA, Rhim H and Silverman SG: Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235: 728-739, 2005.
4. Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo MA, Brandi GL and Seragnoli A: Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 32: 214-228, 2006.
5. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94: 82-99, 2006.
6. Meyerhardt JA and Mayer RY: Systemic therapy for colorectal cancer. New Eng J Med 352: 476-487, 2005
7. Poon RT and Fan ST: Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10: S39-45, 2004.
8. Livraghi T and Meloni F: Treatment of hepatocellular carcinoma by percutaneous interventional methods. Hepatogastroenterology 49: 62-71, 2002.
9. Machi J, Oishi AJ, Sumida K, Sakamoto K, Furumoto NL, Oishi RH and Kylstra JW: Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first-and second-line management. Cancer J 12: 318-326, 2006.
10. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L and Gazelle GS: Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214: 761-768, 2000.
11. Solbiati L, Ierace T, Tonolini M, Osti V and Cova L: Radiofrequency thermal ablation of hepatic metastases Eur J Ultrasound 13: 149-158, 2001.
12. Goldberg SN, Solbiati L, Hahn PF, Cosman E, Conrad JE, Fogle R and Gazelle GS: Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 209: 371-379, 1998.
13. Bruix J and Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 42: 1208-1236, 2005.
14. Parikh AA, Curley SA, Fornage BD and Ellis LM: Radiofrequency ablation of hepatic metastases. Semin Oncol 29: 68-82, 2002.
15. Seidenfeld J, Korn A and Aronson N: Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 195: 378-386, 2002.
16. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K and Curley SA: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-825, 2004.
17. Berber E, Pelley R and Siperstein AE: Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23: 1358-1364, 2005.
18. Berber E, Flesher N and Siperstein AE: Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 26: 985-990, 2002.
19. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G and Elvin A: Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 26: 1052-1056, 2002.
20. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I and Michel L: Complications of radiofrequency coagulation of liver tumours. Br J Surg 89: 1206-1222, 2002.
21. Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S and Charnsangavej C: Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21: S41-54, 2001.
22. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ and Bilchik AJ: Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7: 593-600, 2000.
23. de Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C and Elias D: Adverse events during radiofrequency treatment of 582 hepatic tumors AJR Am J Roentgenol 181: 695-700, 2003.
24. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF and Goldberg SN: Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226: 441-451, 2003.
25. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN and Byun JY: Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 23: 123-134, 2003.
26. Zagoria RJ, Chen MY, Shen P and Levine EA: Complications from radiofrequency ablation of liver metastases. Am Surg 68: 204-209, 2002.
27. Livraghi T, Lazzaroni S, Meloni F and Solbiati L: Risk of tumor seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92: 856-858, 2005.
28. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33: 1124-1129, 2001.
29. Dominique E, El Otmany A, Goharin A, Attalah D and de Baere T: Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol 76: 297-300, 2001.
30. Lieberman S, Goldin E, Lotem M and Bloom AI: Irrigation of the bile duct with chilled saline during percutaneous radiofrequency ablation of a hepatic ocular melanoma metatstasis. Am J Roentgenol 183: 596-598, 2004.